ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Insulin, Regular, Human

Also written as “Technosphere Insulin”, “inhaled human insulin” and “Human Insulin Inhalation Powder”.

Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus · Asthma · Diabetes, Gestational, led by 13 companies.

Drug pageInsulin, Regular, Human: every studyMany companies study it; this page follows only the 79 they lead. All 127 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Apr 16, 202179 company-led studies, 2 open or runningNext primary completion: Mar 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Mannkind261 open or runningphase 4since Apr 16, 2021Mar 27, 2006Mar 2027phase 2 · NCT07224321
Novo Nordiskits history only190 open or runningphase 4since Aug 10, 2006Jul 17, 2003none ahead
Eli Lillyits history only100 open or runningphase 4since Jan 22, 2013Aug 4, 2005none ahead
Biodelits history only50 open or runningphase 3since Oct 5, 2007Oct 5, 2007none ahead
Pfizerits history only40 open or runningphase 3since Feb 2, 2006Feb 2, 2006none ahead
Dance Biopharmits history only30 open or runningphase 2since Mar 9, 2016Mar 9, 2016none ahead
Halozyme Therapeuticsits history only30 open or runningphase 2since Oct 15, 2008Jun 24, 2008none ahead
Sanofiits history only30 open or runningphase 4since Jun 26, 2012Sep 2, 2010none ahead
Transdermal Delivery Solutionsits history only21 open or runningphase 3since Dec 1, 2021Apr 21, 2021Oct 15, 2027phase 3 · NCT05159453
Diabetes and Glandular Disease Clinicits history only10 open or runningphase 4since Oct 9, 2019Oct 9, 2019none ahead

Also a collaborator on its studies: Langford Research Institute, Insulet, DexCom, Profil Institut für Stoffwechselforschung, Alkermes, WCCT Global and Nektar Therapeutics.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Mannkind only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 12 studies since Mar 27, 2006.

  1. Mar 21, 2008Phase 3 study in Diabetes Mellitus, Type 1NCT00642616 · 34 enrolled · United States, Russian Federation, Ukraine
  2. Apr 16, 2008Phase 2 study in Diabetes Mellitus, Type 1NCT00662857 · 29 enrolled · United States
  3. Jun 16, 2008Phase 3 study in Diabetes Mellitus, Type 1NCT00700622 · 130 enrolled · United States, Brazil
  4. Jul 6, 2009Phase 2 study in Diabetes Mellitus, Type 2NCT00934414 · 24 enrolled · United States
  5. Jun 1, 2011Phase 1 study in Healthy VolunteersNCT01365117 · 50 enrolled · United States
  6. Oct 7, 2011Phase 3 study in Diabetes Mellitus, Type 2NCT01451398 · 353 enrolled · United States, Brazil, Russian Federation and more
  7. Feb 23, 2012Phase 1 study in Diabetes Mellitus, Type 1NCT01544881 · 17 enrolled · United States
  8. Jun 25, 2015Phase 1 study in Diabetes Mellitus, Type 1NCT02485327 · 22 enrolled · Germany
  9. Aug 17, 2015Phase 2 study in Diabetes Mellitus, Type 1NCT02527265 · 30 enrolled · United States
  10. Apr 16, 2021Phase 4 study in Diabetes Mellitus, Type 1NCT04849845 · 20 enrolled · United States
  11. Jun 22, 2021Phase 3 study in Diabetes Mellitus, Type 1NCT04974528 · 319 enrolled · United States
  12. Feb 7, 2022Phase 4 study in Diabetes Mellitus, Type 1NCT05243628 · 33 enrolled · United States
  13. Jun 2, 2023Phase 4 study in Diabetes Mellitus, Type 1NCT05904743 · 141 enrolled · United States
  14. Oct 31, 2025Phase 2 study in Diabetes Mellitus, Type 1NCT07224321 · 100 planned · United States

Ahead

  1. Mar 2027Primary completion: phase 2 study in Diabetes Mellitus, Type 1NCT07224321

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 26 Mannkind leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07224321Diabetes Mellitus, Type 1 · United States2RecruitingMar 2027100
NCT05904743Diabetes Mellitus, Type 1 · United States4CompletedMar 26, 2024141
NCT05243628Diabetes Mellitus, Type 1 · United States4CompletedOct 17, 202233
NCT04974528Diabetes Mellitus, Type 1 · United States3CompletedOct 3, 2024319
NCT04849845Diabetes Mellitus, Type 1 · United States4CompletedMay 28, 202120
NCT02527265Diabetes Mellitus, Type 1 · United States2CompletedMar 17, 202030
NCT02485327Diabetes Mellitus, Type 1 · Germany1CompletedNov 201522
NCT01544881Diabetes Mellitus, Type 1 · United States1CompletedSep 201217
NCT01451398Diabetes Mellitus, Type 2 · United States, Brazil, Russian Federation and more3CompletedJun 2013353
NCT01365117Healthy Volunteers · United States1CompletedFeb 201150
NCT00934414Diabetes Mellitus, Type 2 · United States2CompletedAug 200624
NCT00700622Diabetes Mellitus, Type 1 · United States, Brazil3TerminatedNov 2009130
NCT00662857Diabetes Mellitus, Type 1 · United States2CompletedNov 200829
NCT00642616Diabetes Mellitus, Type 1 · United States, Russian Federation, Ukraine3TerminatedNov 201434
NCT00570687Diabetes Mellitus, Type 2 · Germany2CompletedJan 200930
NCT00539890Diabetes Mellitus, Type 2 · Russian Federation3Completed0
NCT00539396Diabetes Mellitus, Type 12Completed110
NCT00511979Healthy1CompletedFeb 200012
NCT00511732Diabetes Mellitus, Type 22CompletedAug 2005227
NCT00511719Diabetes Mellitus, Type 22CompletedApr 200413
NCT00511602Diabetes Mellitus, Type 22CompletedNov 2004123
NCT00332826Diabetes Mellitus, Type 1 · United States, Argentina, Brazil and more3TerminatedOct 20073
NCT00332488Diabetes Mellitus, Type 2 · United States, Argentina, Brazil and more3CompletedMar 2008547
NCT00308737Diabetes Mellitus, Type 1 · United States, Canada, Czech Republic and more3CompletedSep 20082,053
NCT00309244Diabetes Mellitus, Type 2 · United States, Argentina, Brazil and more3CompletedAug 2008677
NCT00308308Diabetes Mellitus, Type 1 · United States, Argentina, Brazil and more3CompletedJul 2008589

How it is read

Names in the registry

  • “Technosphere Insulin”, 13 entries
  • “inhaled human insulin”, 12 entries
  • “Human Insulin Inhalation Powder”, 7 entries
  • “human insulin”, 7 entries
  • “Technosphere® Insulin Inhalation Powder”, 5 entries

Codes read as this program: INH69, INH139, INH208, HR1799.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.